SAVIENT PHARMACEUTICALS, INC. COMPLETES SALE OF ROSEMONT PHARMACEUTICALS LTD. SUBSIDIARY FOR $176 MILLION

Savient Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in developing, manufacturing, and marketing pharmaceutical products that address unmet medical needs, announced that it has completed the sale of its wholly-owned subsidiary, Rosemont Pharmaceuticals Ltd, to an entity affiliated with Close Brothers Private Equity for $176 million. Rosemont is a leading developer, manufacturer and marketer of high quality oral liquid medicines in the United Kingdom.
BioSpace